ELRIG Drug Discovery 2022

4-5 October, ExCel, London

Mark the date

Poster presentation

Patient-Derived Cell (PDC) Models as a Tool to Assess Cancer Therapeutic Efficacy Across the Drug Development Life Cycle
October 4th 2022, 11:40-12:10 BST
Auditorium 1








Don't miss the chance to catch up with our experts attending
ELRIG Drug Discovery 2022 in London. Dr. Rachel Howard-Jones,
Associate Principal Scientist will be presenting about our Patient
derived cell model platform for drug discovery and development on
October 4th.

If you are attending as well and wish to meet one of our team members while in London, get in touch via
the form below, we will be happy to arrange a meeting.

Arrange a meeting

Subscribe to our blog